BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia

Abstract Hairy cell leukemia (HCL) is an uncommon B-cell chronic lymphoproliferative disorder whose pathogenesis and recurrence are strictly dependent on the presence of the BRAF V600E mutant. A 65-year-old male presented a monomorphic epitheliotropic intestinal T-cell lymphoma (formerly enteropathy-associated T-cell lymphoma, type II) with HCL not responding to first-line induction with cladribine. The intestinal lymphoma bears the BRAF V600E mutant, which is the molecular hallmark of HCL, being implicated in its pathogenesis. The case is of interest, as it provides the first description of a BRAF V600E-positive intestinal T-cell lymphoma, along with immunohistochemical and molecular demonstration, occurring in concomitance with HCL. A novel digital PCR-base method for HCL disease assessment is also suggested.

[1]  A. Tzankov,et al.  High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations , 2018, Leukemia.

[2]  P. Gaulard,et al.  Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations , 2016, Nature Communications.

[3]  M. Grever,et al.  Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. , 2015, The New England journal of medicine.

[4]  C. Buske,et al.  Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  S. Pileri,et al.  BRAFV600E mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients , 2015, British journal of haematology.

[6]  C. Cobaleda,et al.  Tumoral reprogramming: Plasticity takes a walk on the wild side. , 2015, Biochimica et biophysica acta.

[7]  M. Berger,et al.  Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia , 2014, Science Translational Medicine.

[8]  M. Vovk,et al.  Coexistent hairy cell leukaemia and hepatosplenic t-cell lymphoma: a case report , 2014, Diagnostic Pathology.

[9]  S. Pileri,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.

[10]  A. Rohatiner,et al.  Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis , 2009, British journal of haematology.

[11]  M. Busslinger,et al.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors , 2007, Nature.

[12]  H. S. Kim,et al.  BRAF mutations in non-Hodgkin's lymphoma , 2003, British Journal of Cancer.

[13]  L. Bonaldi,et al.  Co‐existence of cutaneous T‐cell lymphoma and B hairy cell leukemia , 2000, American journal of hematology.

[14]  Ronan Ward,et al.  The simultaneous presentation of peripheral T‐cell lymphoma and hairy cell leukemia , 1987, Cancer.

[15]  C. Worman,et al.  HAIRY‐CELL LEUKAEMIA , 1985, British journal of haematology.